JacksonL.Cat-scratch disease in the US: an analysis of three national databases. Annual meeting Internal Cong Antimicrob Agents Chemotherap 1992; abst 690. Annaheim.
2.
EnglishC.K., WearD.J., MargilethA.M.Cat-scratch disease: isolation and culture of the bacterial agent. J Am Jed Assoc1991; 259: 1347–1352.
3.
HolleyH.P.Successful treatment of cat-scratch disease with ciprofloxacin. J Am Med Assoc1991; 265: 1563–5.
4.
MargilethA.M.Antibiotic therapy for cat-scratch disease: clinical study of therapeutic outcome in 268 patients and a review of the literature. Pediatr Infect Dis J1992; 11: 474–8.
5.
RelmanD.A., FalkowS., LeBoitP.E.The organism causing bacillary angiomatosis, peliosis hepititis, fever and bacteremia in immunocompromised patients. N Engl J Med1991; 324: 1514–8.
6.
RegeneryR.L., OlsonJ.G.Perkins BA, Bibb W. Serological response to “Rochalimeae henselae” antigen in suspected cat-scratch disease. Lancet1992; 39: 1443–4.
7.
Enzyme immunoassay (EIA) for Rochalimaea henselae, test code 8851, Speciality Laboritories, 2211 Michigan Avenue, Santa Monica, California 90404-3900, ph. 800-421-7110. (1 ml of serum at room temperature).
